INS and pancreatic neoplasm: We found that the expression of genes characteristic of early stem cells, NANOG (p = 0.03), and the expression of genes encoding insulin and cytokeratin 19 (INS p = 0.02, CK19 p = 0.005) were increased in pancreatic cancer patients.